PL353407A1 - Czynnik terapeutyczny do leczenia lekoopornej hiperkalcemii - Google Patents

Czynnik terapeutyczny do leczenia lekoopornej hiperkalcemii

Info

Publication number
PL353407A1
PL353407A1 PL00353407A PL35340700A PL353407A1 PL 353407 A1 PL353407 A1 PL 353407A1 PL 00353407 A PL00353407 A PL 00353407A PL 35340700 A PL35340700 A PL 35340700A PL 353407 A1 PL353407 A1 PL 353407A1
Authority
PL
Poland
Prior art keywords
remedies
drug
resistant hypercalcemia
hypercalcemia
resistant
Prior art date
Application number
PL00353407A
Other languages
English (en)
Inventor
Hidemi Saito
Toshiaki Tsunenari
Etsuro Onuma
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of PL353407A1 publication Critical patent/PL353407A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00353407A 1999-07-06 2000-07-06 Czynnik terapeutyczny do leczenia lekoopornej hiperkalcemii PL353407A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19227099 1999-07-06

Publications (1)

Publication Number Publication Date
PL353407A1 true PL353407A1 (pl) 2003-11-17

Family

ID=16288493

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353407A PL353407A1 (pl) 1999-07-06 2000-07-06 Czynnik terapeutyczny do leczenia lekoopornej hiperkalcemii

Country Status (17)

Country Link
EP (1) EP1195164A4 (pl)
KR (1) KR20020040743A (pl)
CN (1) CN1399557A (pl)
AR (1) AR020867A1 (pl)
AU (1) AU5849700A (pl)
BR (1) BR0012467A (pl)
CA (1) CA2373945A1 (pl)
CZ (1) CZ20014730A3 (pl)
HK (1) HK1046235A1 (pl)
HU (1) HUP0202218A3 (pl)
MX (1) MXPA02000018A (pl)
NO (1) NO20020044L (pl)
PL (1) PL353407A1 (pl)
RU (1) RU2002102916A (pl)
SK (1) SK162002A3 (pl)
WO (1) WO2001002012A1 (pl)
ZA (1) ZA200200264B (pl)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02207099A (ja) * 1989-02-07 1990-08-16 Tonen Corp ＰＴＨｒＰ関連ペプチド、その製造法及び用途
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
JPH04228089A (ja) * 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd 高カルシウム血症治療・予防剤
WO1992000753A1 (en) * 1990-07-13 1992-01-23 The Regents Of The University Of California PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9
DE69233472T2 (de) * 1991-04-05 2006-02-09 The General Hospital Corp., Charlestown Parathormonrezeptor und dafür codierende DNA
US5849695A (en) * 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
JP3504697B2 (ja) * 1993-09-30 2004-03-08 株式会社先端生命科学研究所 ＰＴＨｒＰアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
DE69637481T2 (de) * 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
KR100847441B1 (ko) * 1996-09-26 2008-07-21 츄가이 세이야꾸 가부시키가이샤 인간의 부갑상선 호르몬 관련 펩티드에 대한 항체
JP4372240B2 (ja) * 1997-05-15 2009-11-25 中外製薬株式会社 悪液質治療剤
MXPA00012770A (es) * 1998-06-26 2003-07-14 Chugai Pharmaceutical Co Ltd Agente terapeutico para crisis hipercalcemica.
TWI255718B (en) * 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration

Also Published As

Publication number Publication date
MXPA02000018A (es) 2003-07-21
CN1399557A (zh) 2003-02-26
SK162002A3 (en) 2002-06-04
EP1195164A1 (en) 2002-04-10
BR0012467A (pt) 2002-06-11
HK1046235A1 (en) 2003-01-03
RU2002102916A (ru) 2003-11-10
HUP0202218A2 (en) 2002-10-28
NO20020044D0 (no) 2002-01-04
KR20020040743A (ko) 2002-05-30
NO20020044L (no) 2002-03-01
AR020867A1 (es) 2002-05-29
WO2001002012A1 (fr) 2001-01-11
WO2001002012A8 (fr) 2002-06-06
EP1195164A4 (en) 2005-09-28
ZA200200264B (en) 2003-04-30
CA2373945A1 (en) 2001-01-11
HUP0202218A3 (en) 2005-01-28
AU5849700A (en) 2001-01-22
CZ20014730A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
GB9914222D0 (en) Pharmeceutical compounds
GB0100944D0 (en) Servocontrol
IL150009A0 (en) Immunoassay for neonicotinyl insecticides
EP1247258A4 (en) SOFTWARE BASE STAMP DISTRIBUTOR
IL148406A0 (en) Pharmaceutical tramadol salts
GB9817118D0 (en) Pharmaceutical compounds
GB9817623D0 (en) Pharmaceutical compounds
GB9810886D0 (en) Pharmaceutical compounds
GB9906457D0 (en) Anti-oxidant
IL145632A0 (en) Pharmaceutical compounds
PL345117A1 (en) Remedies for hypercalcemic crisis
GB9916434D0 (en) Pharmaceutical compounds
GB9800750D0 (en) Pharmaceutical compound
GB9914255D0 (en) Pharmaceutical compounds
GB0316320D0 (en) Remedies for dermatophytosis
GB9823847D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
GB9823845D0 (en) Pharmaceutical compounds
GB2373499B (en) Pharmaceutical compounds
HUP0202218A3 (en) Remedies for drug-resistant hypercalcemia
GB9930591D0 (en) Component for vaccine
EP1170007A4 (en) DRUGS
GB9817197D0 (en) Pharmaceutical compounds
GB9920826D0 (en) Brake
GB9904312D0 (en) Platform

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)